About Scott A Rivkees
Scott A. Rivkees, MD, earned his undergraduate degree from Rutgers University and his medical degree from the University of Medicine and Dentistry of New Jersey in 1982. He completed his residency training and fellowships in pediatrics, pediatric endocrinology and neuroscience at Harvard Medical School and Massachusetts General Hospital.
Prior to joining the University of Florida, he served as a professor and associate chair of pediatrics for research at the Yale University School of Medicine. He also led the department’s section on developmental endocrinology and biology and served as director of the Yale Child Health Research Center and the Yale Pediatric Thyroid Center. Prior to joining Yale in 1996, he held appointments at Harvard Medical School and Indiana University.
An internationally renowned expert on developmental biology and pediatric endocrinology, Dr. Rivkees leads a robust clinical and basic science research program. Key areas of study in his lab are the prevention of brain injury in premature infants, the effects of adenosine on the developing embryo, circadian biology and thyroid diseases. In 2009, he detected a safety problem with a common thyroid medication. One in 2,000 children who were on the medication were going into liver failure or dying each year, and his discovery led to global changes in medical practice.
A fellow of the American Academy of Pediatrics, he has been named one of America’s Best Doctors® as well as one of America’s Top Pediatricians and one of New York’s Best Doctors. His work with pediatric thyroid disease has led to new treatment guidelines in thyroid cancer and Graves’ disease worldwide.
Dr. Rivkees received the George H. Cook Distinguished Alumnus Award from Rutgers University and the Distinguished Alumnus Award from the University of Medicine and Dentistry of New Jersey. He has been elected to the American Society for Clinical Investigation and to be a Fellow of the American Association for the Advancement of Science. He has testified before the U.S. Senate on pediatric issues.
Dr. Rivkees has more than 280 publications and continuous funding from the National Institutes of Health for more than 26 years.
Pediatric EndocrinologyAmerican Board of Pediatrics
PediatricsAmerican Board of Pediatrics
- Pediatric Endocrinology
- Graves disease
- Thyroid diseases
Dr. Rivkees developed a research program that is focused in three major areas: circadian biology, adenosinergic influences on brain injury of prematurity and the discovery of novel pediatric diagnostics and therapeutics. He discovered that the biological clock of preterm infants is responsive to low intensity lighting, leading to new treatment practices for preterm infants. He discovered that A1 adenosine receptor activation induces periventricular white matter injury (PWMI)-the most common neurological disorder affecting premature infants. He has recently discovered adverse effects on body composition and heart function related to prenatal caffeine exposure, findings reported widely in the press. Recently, he started a new research program aimed at the development of novel pediatric diagnostics and therapeutics. Moist recently the Rivkees laboratory has begun to focus on the risks and adverse events associated with Graves’ disease therapy in children and during during pregnancy.
- Prevention of Brain Injury
- Circadian Biology
- Developmental Endocrinology
- Thyroid Diseases